Medicare Enrolled

Dr. Shan Chu, MD

Pulmonary Disease · Monterey Park, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
500 N GARFIELD AVE, Monterey Park, CA 91754
6262804393
In practice since 2005 (20 years)
NPI: 1760477939 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chu

Dr. Shan Chu is a pulmonary disease specialist in Monterey Park, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chu performed 3,372 Medicare services across 1,156 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chu received a total of $6,270 from 26 pharmaceutical and/or device companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 9% volume in CA $6,270 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,372
Medicare services
Top 9% in CA for pulmonary disease
1,156
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~169 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Nursing facility visit, high complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes.
1,113 $130 $370
Nursing facility visit, moderate complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes.
903 $90 $250
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
295 $102 $303
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
215 $100 $283
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
177 $67 $205
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
119 $33 $249
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
119 $38 $130
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
119 $51 $140
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
109 $93 $175
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
57 $121 $453
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
42 $66 $195
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
42 $67 $126
Pneumococcal vaccine, 23-valent
A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria.
21 $131 $150
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
21 $33 $50
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
20 $150 $410
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,270
Total received (2018-2024)
Avg $896/year across 7 years
Top 24% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
165
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,211 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$59 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$771
2023
$639
2022
$904
2021
$672
2020
$174
2019
$1,205
2018
$1,904

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$250
Boehringer Ingelheim Pharmaceuticals, Inc.
$156
Actelion Pharmaceuticals US, Inc.
$133
GlaxoSmithKline, LLC.
$120
Electromed, Inc.
$61
GENZYME CORPORATION
$34
Mylan Specialty L.P.
$18
Top 3 companies account for 69.9% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,431
AstraZeneca Pharmaceuticals LP
$1,317
Boehringer Ingelheim Pharmaceuticals, Inc.
$862
Genentech USA, Inc.
$689
Actelion Pharmaceuticals US, Inc.
$351
Merck Sharp & Dohme Corporation
$192
Allergan Inc.
$145
Intuitive Surgical, Inc.
$132
Electromed, Inc.
$131
AbbVie, Inc.
$125
PORTOLA PHARMACEUTICALS, INC.
$124
Boston Scientific Corporation
$121
Pulmonx Corporation
$104
PFIZER INC.
$79
Radius Health, Inc.
$68
Merck Sharp & Dohme LLC
$68
Sunovion Pharmaceuticals Inc.
$58
GENZYME CORPORATION
$54
Otsuka America Pharmaceutical, Inc.
$47
Mylan Specialty L.P.
$42
Baxter Healthcare
$34
Insmed, Inc.
$24
Shionogi Inc
$21
Advanced Respiratory, Inc
$17
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$16
ABBVIE INC.
$16
Top 3 companies account for 57.6% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · AVYCAZ · Arikayce · BEVYXXA · BREZTRI · CHARTIS CATHETER · CRE · CUBICIN RF · DALVANCE · DUPIXENT · Da Vinci Surgical System · EUCRISA · Esbriet · FARXIGA · FASENRA · Fetroja · Hillrom - Vest System Model 105 Home Care · LONHALA MAGNAIR · LifeVest · NUCALA · OFEV · OPSUMIT MACITENTAN · PREVNAR 20 · SAMSCA · SMARTVEST · SPIRIVA · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · The Vest System Model 105 Home Care · Tymlos · UPTRAVI · Utibron · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Monterey Park?
Compare pulmonary diseases in the Monterey Park area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
301
Per 100K population
3.1
County median income
$87,760
Nearest hospital
MONTEREY PARK HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chu is a clinical cardiology specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chu experienced with nursing facility visit, high complexity?
Based on Medicare claims data, Dr. Chu performed 1,113 nursing facility visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chu receive payments from pharmaceutical companies?
Yes. Dr. Chu received a total of $6,270 from 26 companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chu's costs compare to other pulmonary diseases in Monterey Park?
Dr. Chu's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →